| 1 |
35078112 | Stabilization of VEGF i-motif structure by CpG methylation. | 2022 Feb 26 |
1 |
| 2 |
33038031 | Anti-VEGF DNA-based aptamers in cancer therapeutics and diagnostics. | 2021 Jan |
2 |
| 3 |
32442276 | Modular protein-oligonucleotide signal exchange. | 2020 Jul 9 |
1 |
| 4 |
30682194 | Quadruplex-forming oligonucleotide targeted to the VEGF promoter inhibits growth of non-small cell lung cancer cells. | 2019 |
7 |
| 5 |
30563296 | Design and Properties of Ligand-Conjugated Guanine Oligonucleotides for Recovery of Mutated G-Quadruplexes. | 2018 Dec 6 |
2 |
| 6 |
28082399 | Radiation-Induced Enhancement of Antitumor T-cell Immunity by VEGF-Targeted 4-1BB Costimulation. | 2017 Mar 15 |
1 |
| 7 |
26678602 | Targeting VEGF in eye neovascularization: What's new?: A comprehensive review on current therapies and oligonucleotide-based interventions under development. | 2016 Jan |
1 |
| 8 |
25201604 | NKCC1 mediates traumatic brain injury-induced hippocampal neurogenesis through CREB phosphorylation and HIF-1α expression. | 2015 Aug |
1 |
| 9 |
25553085 | Upregulation of miRNA3195 and miRNA374b Mediates the Anti-Angiogenic Properties of Melatonin in Hypoxic PC-3 Prostate Cancer Cells. | 2015 |
2 |
| 10 |
25949891 | Reducing toxicity of 4-1BB costimulation: targeting 4-1BB ligands to the tumor stroma with bi-specific aptamer conjugates. | 2015 Mar |
1 |
| 11 |
23571736 | Toll-like receptor 9 agonist IMO cooperates with everolimus in renal cell carcinoma by interfering with tumour growth and angiogenesis. | 2013 Apr 30 |
2 |
| 12 |
21860419 | FOXO3a represses VEGF expression through FOXM1-dependent and -independent mechanisms in breast cancer. | 2012 Apr 5 |
1 |
| 13 |
22415802 | Angiogenic functionalisation of titanium surfaces using nano-anchored VEGF - an in vitro study. | 2012 Mar 13 |
2 |
| 14 |
22664115 | Targeted inhibition of VEGF-modulated survival and arsenic sensitivity in acute myeloid leukemia (AML). | 2012 May |
1 |
| 15 |
21708999 | IL-6 antisense-mediated growth inhibition in a head and neck squamous cell carcinoma cell line. | 2011 Jul-Aug |
1 |
| 16 |
21740819 | Inhibitory effect of 2'-o-methoxyethyl-modified antisense oligonucleotides targeting vascular endothelial growth factor A on SKOV3 human ovarian cancer cells. | 2011 May |
9 |
| 17 |
20387247 | [Construction of VEGF gene-targeted small interfering RNA mediated by CMV promoter and its silencing effect]. | 2010 Mar |
1 |
| 18 |
20831905 | Controlled DNA "damage" and repair in hypoxic signaling. | 2010 Dec 31 |
1 |
| 19 |
19426694 | Impact of alendronate and VEGF-antisense combined treatment on highly VEGF-expressing A431 cells. | 2009 May 15 |
1 |
| 20 |
19562672 | A new mechanism of gastric epithelial injury induced by acid exposure: the role of Egr-1 and ERK signaling pathways. | 2009 Sep 1 |
1 |
| 21 |
19845616 | Oxidative DNA modifications in hypoxic signaling. | 2009 Oct |
1 |
| 22 |
19903791 | A novel toll-like receptor 9 agonist cooperates with trastuzumab in trastuzumab-resistant breast tumors through multiple mechanisms of action. | 2009 Nov 15 |
1 |
| 23 |
19907859 | [The effect of VEGF-ASODN transfection on expression of VEGF and growth in tongue squamous cancer cell line Tca8113]. | 2009 Oct |
3 |
| 24 |
18265796 | [New drugs; pegaptanib and ranibizumab]. | 2008 Jan 12 |
1 |
| 25 |
18787075 | Epoxyeicosatrienoic acids are part of the VEGF-activated signaling cascade leading to angiogenesis. | 2008 Nov |
1 |
| 26 |
18813854 | Abrogation of TGF-beta by antisense oligonucleotides modulates expression of VEGF and increases angiogenic potential in isolated fibroblasts from radiated skin. | 2008 Oct |
2 |
| 27 |
17174722 | Tgf-beta antisense therapy increases angiogenic potential in human keratinocytes in vitro. | 2007 Jan |
1 |
| 28 |
17187248 | Placental growth factor-1 and epithelial haemato-retinal barrier breakdown: potential implication in the pathogenesis of diabetic retinopathy. | 2007 Feb |
1 |
| 29 |
17278099 | Increased expression of VEGF121/VEGF165-189 ratio results in a significant enhancement of human prostate tumor angiogenesis. | 2007 May 15 |
4 |
| 30 |
17636117 | TLR9 agonist acts by different mechanisms synergizing with bevacizumab in sensitive and cetuximab-resistant colon cancer xenografts. | 2007 Jul 24 |
1 |
| 31 |
17708817 | [Effect of vascular endothelial growth factor antisense oligonucleotide on human leukemic cell line HL-60]. | 2007 Aug |
3 |
| 32 |
17767065 | [Effect of EphA2 protein on the expression of VEGF and MMP9 proteins in HCT116 cells]. | 2007 Aug |
1 |
| 33 |
15949808 | NOR-1 is involved in VEGF-induced endothelial cell growth. | 2006 Feb |
1 |
| 34 |
16327989 | Extracellular signal-regulated kinases and AP-1 mediate the up-regulation of vascular endothelial growth factor by PDGF in human vascular smooth muscle cells. | 2006 Jan |
1 |
| 35 |
16337972 | Vascular endothelial growth factor-induced endothelial cell proliferation is regulated by interaction between VEGFR-2, SH-PTP1 and eNOS. | 2006 Jan |
1 |
| 36 |
16520466 | Phase I study of antisense oligonucleotide against vascular endothelial growth factor: decrease in plasma vascular endothelial growth factor with potential clinical efficacy. | 2006 Apr 10 |
5 |
| 37 |
16540671 | EGFR tyrosine kinase inhibitors decrease VEGF expression by both hypoxia-inducible factor (HIF)-1-independent and HIF-1-dependent mechanisms. | 2006 Mar 15 |
1 |
| 38 |
16603365 | Synthesis of a library of polycationic lipid core dendrimers and their evaluation in the delivery of an oligonucleotide with hVEGF inhibition. | 2006 Jul 15 |
1 |
| 39 |
16838842 | Inhibition of VEGF mRNA by 2'-O,4'-C-ethylene-bridged nucleic acids (ENA) antisense oligonucleotides and their influence on off-target gene expressions. | 2006 |
3 |
| 40 |
17097190 | Ocular delivery of nucleic acids: antisense oligonucleotides, aptamers and siRNA. | 2006 Nov 15 |
1 |
| 41 |
15608422 | Antiangiogenic therapy of head and neck squamous cell carcinoma by vascular endothelial growth factor antisense therapy. | 2005 |
5 |
| 42 |
15649872 | Cyr61 mediates the expression of VEGF, alphav-integrin, and alpha-actin genes through cytoskeletally based mechanotransduction mechanisms in bladder smooth muscle cells. | 2005 Jun |
1 |
| 43 |
15674201 | VEGF antisense therapy inhibits tumor growth and improves survival in experimental pancreatic cancer. | 2005 Feb |
1 |
| 44 |
15924643 | [The inhibitory effect of vascular endothelial growth factor antisense oligonucleotides in angiogenesis of thyroid carcinoma]. | 2005 Apr |
3 |
| 45 |
16103054 | Hepatocyte growth factor/scatter factor differentially regulates expression of proangiogenic factors through Egr-1 in head and neck squamous cell carcinoma. | 2005 Aug 15 |
1 |
| 46 |
14726684 | Pharmacodynamic behavior of liposomal antisense oligonucleotides targeting Her-2/neu and vascular endothelial growth factor in an ascitic MDA435/LCC6 human breast cancer model. | 2004 Feb |
2 |
| 47 |
14757519 | Vascular endothelial growth factor promotes neurite maturation in primary CNS neuronal cultures. | 2004 Jan 31 |
1 |
| 48 |
14761281 | [Inhibitory effects of antisense oligonucleotides on VEGF gene expression by human hepatocellular carcinoma cells]. | 2004 Jan |
2 |
| 49 |
14990072 | [VEGF antisense oligonucleotide inhibits the expression of vascular endothelial growth factor in human leukemic cell lines]. | 2004 Jan |
2 |
| 50 |
15003510 | Transcriptional regulation of human angiopoietin-2 by transcription factor Ets-1. | 2004 Mar 26 |
1 |